Financing Will Support Development of Tioga Medical's Transcatheter Valve Technology
April 4, 2019—Tioga Medical announced today the closing of its Series A preferred stock financing, raising $15 million. The funds will be used to advance Tioga Medical's preclinical and clinical development programs. Tioga Medical is developing a novel transcatheter valve replacement technology for mitral and tricuspid applications.
Tioga Medical is a newly formed company in the portfolio of Shifamed, LLC, which is a specialized medical innovation hub founded by Amr Salahieh. The financing was led by The Capital Partnership, with significant participation from Cormorant Healthcare Fund, AMED Ventures, and Shangbay Capital reported the company.